MannKind

Why Shares of MannKind Were Up Wednesday
Motley Fool
Thu, 05/11/23 - 09:56 am
MannKind
earnings
United Therapeutics
If at first... pharma’s most drawn-out development timelines revealed
EP Vantage
Thu, 11/3/22 - 10:54 am
Kyowa Kirin
Takeda
Eiger BioPharmaceuticals
AstraZeneca
Teva Pharmaceutical
Bavarian Nordic
Halozyme
Novartis
MannKind
drug development
After buying in candidate, Mannkind wraps up phase 1 trial of inhaled lung infection prospect
Fierce Pharma
Tue, 09/6/22 - 12:04 pm
MannKind
clofazimine
FDA
bacterial lung infections
clinical trials
MannKind Acquires Wearable Insulin Device from Zealand Pharma
Medical Devices and Diagnostics Industry
Tue, 05/17/22 - 10:27 pm
MannKind
Zealand Pharma
V-Go
insulin
diabetes
devices
Medtech
FDA declines to approve United-MannKind's lung disease therapy
Yahoo/Reuters
Mon, 10/18/21 - 10:42 pm
MannKind
United Therapeutics
Tyvaso
FDA
PAH
MannKind and United Snag Priority Review for Pulmonary Hypertension Drug
BioSpace
Wed, 06/16/21 - 11:17 pm
MannKind
United Therapeutics
PAH
PH-ILD
FDA
priority review
Tyvaso
Five Collaborations Unlocking Faster Drug Development this Week
BioSpace
Thu, 06/10/21 - 11:12 am
drug development
MannKind
Thirona Bio
pulmonary fibrosis
Oyster Point Pharma
Adaptive Phage Therapeutics
ophthalmic
Takeda
Codexis
ALX Oncology
Eli Lilly
clinical trials
BeiGene
Shoreline Biosciences
oncology
Why MannKind Stock Crushed it Monday
Motley Fool
Mon, 06/15/20 - 11:03 pm
MannKind
ADA
diabetes
insulin
Afrezza
inhaled insulin
Why MannKind Is Up Big Today
Motley Fool
Tue, 05/14/19 - 05:00 pm
MannKind
inhaled insulin
Afrezza
MannKind (MNKD) Q4 Revenues Rise 254%; Achieves First Ever Qtr Afrezza Gross Profit
Street Insider
Tue, 02/26/19 - 06:34 pm
MannKind
earnings
Afrezza
FDA’s OPDP Warns MannKind for Facebook Post
RAPS.org
Tue, 10/16/18 - 11:52 pm
Afrezza
warning letter
FDA
OPDP
Facebook
social media
diabetes
MannKind
Struggling MannKind sees shares rocket up on $105M-plus alliance with United on inhaled treprostinil
Endpoints
Tue, 09/4/18 - 09:43 am
MannKind
United Therapeutics
PAH
Treprostinil
Can MannKind Corporation Avert Bankruptcy?
Motley Fool
Fri, 08/3/18 - 10:55 pm
MannKind
earnings
Afrezza
MannKind (MNKD) Completes Phase 1 Trial of Treprostinil Technosphere for PAH Advancing Development to Next Phase
Street Insider
Fri, 06/8/18 - 11:00 am
MannKind
TreT
FDA
PAH
MannKind Q1 Results: The Good, the Bad, and the Ugly
Motley Fool
Thu, 05/10/18 - 09:16 am
MannKind
earnings
Why MannKind Corporation Stock Broke Down in April
Motley Fool
Tue, 05/8/18 - 09:54 am
MannKind
3 Bright Spots in MannKind Corporation's Q4 Update
Motley Fool
Wed, 02/28/18 - 06:47 pm
MannKind
earnings
Why MannKind Corporation Stock Is Falling Back to Earth Today
Motley Fool
Fri, 01/26/18 - 05:23 pm
MannKind
diabetes
Afrezza
3 Fastest-Growing Diabetes Stocks of 2018 -- According to Wall Street
Motley Fool
Sun, 01/21/18 - 10:47 am
diabetes
Senseonics
Lexicon Pharmaceuticals
MannKind
Why MannKind Corporation Jumped Higher Today
Motley Fool
Tue, 01/2/18 - 07:25 pm
MannKind
diabetes
Afrezza

Pages